Warsaw Genomics

Genetic testing · Hereditary cancer risk

Overview

University-of-Warsaw spinout offering large-scale, low-cost genetic testing for hereditary cancer predisposition.

What they do

Warsaw Genomics is a genetic-diagnostics company spun out of the University of Warsaw, founded by a team of physicians, biologists, geneticists, bioinformaticians and mathematicians. Its mission, championed by founder Prof. Krystian Jażdżewski, an oncogeneticist and endocrinologist, is to make genetic testing affordable and accessible to every Polish citizen. The laboratory operates within the University's Biological and Chemical Research Centre and is registered in the U.S. NIH Genetic Testing Registry.

Lead program & status

The flagship offering is next-generation-sequencing panels for hereditary cancer-risk assessment, estimating predisposition to cancers such as breast, ovarian and colorectal disease. For patients with active cancer, the company performs somatic tumour profiling to flag mutations potentially targetable by personalized therapy. Warsaw Genomics has run large-scale population testing programs and validated multi-gene hereditary-cancer panels. Through 2024, Prof. Jażdżewski has publicly advocated integrating genetic screening into Poland's national healthcare and prevention pathways. As a commercial diagnostics lab, its products are services on the market rather than investigational drug candidates.

Why it matters

By driving down the cost of comprehensive hereditary-cancer panels, Warsaw Genomics aims to shift Polish oncology toward early, preventive identification of at-risk individuals, where early detection and surveillance can materially change outcomes.

FAQ

Who founded Warsaw Genomics?

It is a University of Warsaw spinout founded by a multidisciplinary team led by oncogeneticist Prof. Krystian Jażdżewski.

What tests does Warsaw Genomics offer?

It offers NGS-based hereditary cancer-risk panels and somatic tumour profiling, alongside other genetic-diagnostic services.

Is Warsaw Genomics a drug developer?

No. It is a genetic-diagnostics laboratory providing testing services rather than developing investigational therapeutics.

Company website / source ↗ Open the interactive map →